Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure.

Varzideh, Fahimeh, Pasquale Mone, Luigi Salemme, Imma Forzano, Angelo Cioppa, Tullio Tesorio, and Gaetano Santulli. “Myosin Activator Omecamtiv Mecarbil Exhibits Divergent Inotropic and Lusitropic Effects in Cardiac Slices from Patients With Heart Failure.”. Journal of Molecular and Cellular Cardiology Plus 5 (2023): 100041.
Last updated on 01/13/2025
PubMed